EPT Disclosure
May 16 2006 - 8:17AM
UK Regulatory
RNS Number:0474D
GoldmanSachs International
16 May 2006
FORM 38.5
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
(Rule 38.5 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of exempt principal trader Goldman Sachs International
Company dealt in CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
Class of relevant security to which the Ordinary Shares
dealings being disclosed relate (Note 1)
Date of dealing 15 May 2006
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3)
704247 24.4685 GBP 12.8405 GBP
Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3)
111750 13.0691 GBP 13.0691 GBP
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)
e.g. CFD
CFD Short 2000 12.9908 GBP
CFD Long 50000 12.9219 GBP
CFD Long 78205 12.9396 GBP
CFD Long 33605 12.9396 GBP
CFD Long 16182 12.9396 GBP
CFD Long 200000 12.9193 GBP
CFD Long 2950 12.9841 GBP
CFD Long 52137 12.9626 GBP
CFD Long 22403 12.9626 GBP
CFD Long 10788 12.9626 GBP
CFD Long 34500 12.884 GBP
CFD Long 5500 12.884 GBP
CFD Long 43000 12.884 GBP
CFD Long 13500 12.884 GBP
CFD Long 3500 12.884 GBP
CFD Long 4227 12.9129 GBP
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities to Exercise Type, e.g. Expiry Option money
purchasing, which the option relates American,
e.g. call varying etc. (Note 5) price European date paid/received per
option etc. unit (Note 3)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
Date of disclosure 16 May 2006
Contact name Peter Highton
Telephone number +44-207-774-1935
Name of offeree/offeror with which connected Astrazeneca
Nature of connection (Note 6) Advisor
Notes
The Notes on Form 38.5 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMSFMFEMSMSEFI
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
